BakerA. R.; FournierR. L.; SarverJ. G.; LongJ. L.; GoldblattP. J.; HornerJ. M.; SelmanS. H.Evaluation of an immunoisolation membrane formed by incorporating a polyvinyl alcohol hydrogel within a microporous filter support.Cell Transplant.6: 585–595; 1997.
2.
BensonJ. P.; PapasK. K.; ConstantinidisI.; SambanisA.Towards the development of a bioartificial pancreas: Effects of poly-L-lysine on alginate beads with BTC3 cells.Cell Transplant.6: 395–402; 1997.
EmerichD. F.; CainC. K.; GrecoC.; SaydoffJ. A.; HuZ. Y.; LiuH.; LindnerM. D.Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.Cell Transplant.6: 249–266; 1997.
5.
EmerichD. F.; BruhnS.; ChuY.; KordowerJ. H.Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.Cell Transplant.7: 213–225; 1998.
6.
EnosawaS.; SuzukiS.; FujinoM.; AmemiyaH.; OmasaT.; UrayamaS.; TanimuraN.; SugaK.An attempt to add biological functions by genetic engineering in order to produce high-performance bioreactor cells for hybrid artificial liver: Transfection of glutamine synthetase into Chinese hamster ovary (CHO) cell.Cell Transplant.6: 537–540; 1997.
7.
HagiharaY.; SaitohY.; IwataH.; TakiT.; HiranoS. I.; AritaN.; HayakawaT.Transplantation of xenogeneic cells secreting β-endorphin for pain treatment: Analysis of the ability of components of complement to penetrate through polymer capsules.Cell Transplant.6: 527–530: 1997.
8.
HirotaniS.; OhgawaraH.Complement permeability in bio-artificial endocrine pancreas using a diffusion chamber.Cell Transplant.7: 407–410; 1998.
9.
KanaiN.; MoritaN.; MunkhbatB.; GansuvdB.; HagiharaM.; NagamachiY.; TsujiK.In vitro and in vivo grafting of xeno pig fetal liver fragments using ultrafiltration membrane.Cell Transplant.7: 417–420; 1998.
10.
KawakamiY.; InoueK.; HayashiH.; WangW. J.; SetoyamaH.; GuY. J.; ImamuraM.; IwataH.; IkadaY.; NozawaM.; MiyazakiJ. I.Subcutaneous xenotransplantation of hybrid artificial pancreas encapsulating B cell line (MIN6): Functional and histological study.Cell Transplant.6: 541–545: 1997.
11.
KawakamiY.; InoueK.; TunT.; HayashiH.; SetoyamaH.; GuY. J.; CuiW. X.; ImamuraM.; IwataH.; IkadaY.Prolonged effect of troglitazone (CS-045) on xenograft survival of hybrid artificial pancreas.Cell Transplant.6: 547–550: 1997.
12.
KulsengB.; ThuB.; EspevikT.; Skjåk-BrækG.Alginate polylysine microcapsules as immune barrier: Permeability of cytokines and immunoglobulins over the capsule membrane.Cell Transplant.6: 387–394; 1997.
13.
LindnerM. D.; EmerichD. F.Therapeutic potential of a polymer-encapsulated L-DOPA and dopamine-producing cell line in rodent and primate models of Parkinson's disease.Cell Transplant.7: 165–174: 1998.
14.
SanbergP. R.; BrundinP.Cell transplantation and neuroscience.Cell Transplant.8: 3–6; 1999.
15.
SuzukiK.; Bonner-WeirS.; Hollister-LockJ.; ColtonC. K.; WeirG. C.Number and volume of islets transplanted in immunobarrier devices.Cell Transplant.7: 47–52; 1998.
16.
WangL.; SunJ.; LiL.; MearsD.; HorvatM.; SheilA. G.Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support.Cell Transplant.7: 459–468; 1998.